Companion Spine completes the integration of Paradigm Spine, unifying its portfolio of posterior dynamic stabilization and controlled motion technologies under its SMART Solutions™ strategy to address the continuum of lumbar spinal stenosis ("LSS") and degenerative disc disease ("DDD")
The combined company now operates as one organization across the U.S. and international markets, with a global footprint spanning 36 countries and 82 employees across 6 locations.
Companion Spine Announces Completion of Paradigm Spine Integration, Establishing a Unified Global Leader in Posterior Dynamic and Controlled Motion Spine Solutions
4 min read Premium comments
acquisitionCompanion SpineAnthony G. ViscogliosiEnrico SangiorgioParadigm Spineintegration
BOURDEAUX, France and NEW YORK and LEESBURG, Va., Oct. 28, 2026 /PRNewswire/ -- Companion Spine, the French-American specialist in surgeon-innovated spine implant surgery, today announced the successful completion of the integration of Paradigm Spine following its acquisition in December 2025. The two companies now operate as one organization across the United States and international markets, bringing together complementary technologies, teams and expertise to advance comprehensive, patient-centered solutions for degenerative spine conditions. With operations now consolidated, the combined organization has offices in Leesburg (VA), New York (NY), Bordeaux (France) and Wurmlingen (Germany), with commercial activities spanning 36 countries, approximately 82 employees and 6 locations.
"This is an important milestone for Companion Spine and for our teams globally. The completion of this integration brings together two highly complementary organizations with a shared history, deep clinical expertise, and a common commitment to advancing posterior dynamic stabilization and delivering comprehensive, patient-centered, controlled-motion preserving solutions for degenerative spine conditions. We are now operating as one company, with the people, technologies, and global reach required to execute on our vision of addressing the needs of a large, underserved patient population across two disease states: degenerative disc disease ("DDD") and lumbar spinal stenosis ("LSS"). This is where our strategic vision becomes an operational reality." said Anthony G. Viscogliosi, Executive Chairman and Chief Executive Officer of Companion Spine.
A comprehensive strategy addressing LSS and DDD
At the heart of the unified company is Companion Spine's SMART Solutions™ (Solution-based, Minimal Access, Reliable Technologies) strategy, which brings together a comprehensive portfolio of indication-specific technologies designed to address different stages and clinical needs across the continuum of degenerative spine disease. The unified portfolio includes, DIAM™, coflex® and CoFix™, for the US Market, and DIAM™, coflex®, CoFix™, HPS™ 2.0, LISA™ and DCI™, among others for the international market, combining complementary minimally invasive, posterior dynamic stabilization and motion-preserving solutions.
Together, these technologies support surgeons in selecting treatment options based on each patient's specific pathology and functional status, with the aim of preserving spinal motion, protecting natural anatomy and maintaining future treatment options, where clinically appropriate.
"Our strategy is to provide surgeons with the right solution for the right patient at the right stage of disease. By combining the complementary expertise of both companies, we have built a global platform designed around the needs of patients and surgeons. Our teams can now work together across markets to support our partners and expand access to our technologies," said Enrico Sangiorgio, Global President at Companion Spine.
Building the next chapter of Companion Spine
With the integration now complete, Companion Spine enters its next phase as a unified global organization focused on degenerative spine disease and the development of posterior dynamic solutions and controlled-motion technologies. Companion Spine exhibited at NASS on October 14 to 17, 2026 in San Antonio, Texas, providing opportunities to engage with surgeons, healthcare professionals and industry stakeholders.
About Companion Spine
Founded in 2020 in New York, United States, and Bordeaux, France, Companion Spine is the only pure-play, multi-product, global company exclusively focused on controlled motion preservation spine care, with a posterior dynamic stabilization implant portfolio spanning the full continuum of care for addressing the largest unmet patient population need across two disease states: Degenerative Disc Disease and Lumbar Spinal Stenosis (DDD & LSS). Our mission is to deliver the right treatment, for the right patient, at the right time. We support a structured assessment of degenerative disc disease (DDD) and lumbar spinal stenosis (LSS), guiding the stage-appropriate use of our SMART Solutions™ (Solution-based, Minimal Access, Reliable Technologies) within the continuum of care, based on pathology and functional status. By matching each patient with the most appropriate stabilization and minimally invasive option for their specific condition, we aim to preserve spinal motion, protect natural anatomy, and maintain spinal health for as long as possible by restoring form, function, motion, balance, alignment and stability while supporting the relief of pain. Companion Spine is committed to advancing long-term, clinically proven, safe, effective and adaptable solutions that enable patients to stay active, mobile, and engaged in life. For more information, please visit: www.companion-spine.com
About Viscogliosi Brothers, LLC
Viscogliosi Brothers is a family-owned New York City-based single family office dedicated to driving growth and innovation in the neuro-musculoskeletal industry. Established in 1999, the firm focuses on identifying and building groundbreaking innovations in healthcare, aiming to address unmet clinical needs, enhance patient outcomes, and drive cost efficiency in the healthcare system. Since its inception in 1999, Viscogliosi Brothers has founded, financed, operated and grown 46 businesses with operations and distribution across more than 80 countries. These businesses have positively impacted millions of patients with leading innovations in healthcare. The firm has led the transformation of multiple market segments in the spine industry specifically including: Spine Solutions, Spine Next, Paradigm Spine, K2M, Simplify Medical, Centinel Spine, Companion Spine, Spine BioPharma, Woven Orthopedics Technologies and VB Spine, among others. For more information, please visit: www.vbllc.com.
About Viscogliosi Brothers Watermark LLC ("VBW")
Viscogliosi Brothers Watermark LLC is a New York City-based holding company specializing in investing in innovation within the MedTech sector. Founded in 2022, VBW is committed to creating wealth for its shareholders while enhancing humanity's well-being. With a portfolio-driven investment mandate and strategic expertise, VBW supports its invested entities through financing and manufacturing support capabilities. For more information, visit www.vbwholdings.com.
Contacts
Companion Spine
Anthony G. Viscogliosi
Executive Chairman and Chief Executive Officer
aviscogliosi@vbllc.com
Enrico Sangiorgio
Global President
esangiorgio@paradigmspine.com
SOURCE Companion Spine USA LLC
Author
TH
TJ Halvorson
The De Angelis Group | Orthopedics This Week | MSK Innovations
Why This Matters
Two Perspectives
MBA Lens: Economic and industry impact
Companion Spine completed its integration of Paradigm Spine, creating a unified global leader in posterior dynamic and controlled motion spine solutions. This strategic move consolidates operations across 36 countries with 82 employees, targeting the continuum of lumbar spinal stenosis and degenerative disc disease. The combined entity leverages its SMART Solutions™ strategy to enhance market presence and address a large, underserved patient population.
- The integration establishes a unified global platform, expanding market reach and operational efficiency across the U.S. and international markets.
- The company's strategy focuses on a comprehensive portfolio under SMART Solutions™ to address the continuum of LSS and DDD, optimizing treatment selection.
PhD Lens: Clinical and outcomes impact
Companion Spine's integration unifies a portfolio of posterior dynamic stabilization and controlled motion technologies, aiming to preserve spinal motion and protect natural anatomy for degenerative disc disease and lumbar spinal stenosis. The SMART Solutions™ strategy guides the use of minimally invasive, motion-preserving implants like DIAM™, coflex®, and CoFix™, enabling stage-appropriate treatment based on patient pathology and functional status.
- The unified portfolio includes devices such as DIAM™, coflex®, CoFix™, HPS™ 2.0, LISA™, and DCI™, designed for minimally invasive, posterior dynamic stabilization.
- Clinical objectives focus on preserving spinal motion, protecting natural anatomy, and maintaining future treatment options, supporting a structured assessment for DDD and LSS.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.